Researchers in the Biomedical Engineering Department at Columbia University have developed a methodology utilizing mesenchymal stem cells [the type of stem cells found in teeth] to engineer fibroblast tissue in the ACL. The stem cells were treated with both chemical growth factors and mechanical factors [scaffolding and mechanical stimuli], which enhanced the regeneration of connective tissue.
A tear in the anterior cruciate ligament (ACL) is a common sports injury that can include surgery, months of physical rehabilitation, and long-term damage to the knee. This study advances stem cell based therapies [and in a best case scenario, will use the patient’s own stem cells] to expedite the healing process after an otherwise devastating injury.
The research is an example of how scientists are gaining insights that will facilitate more effective regenerative treatments and lead to better outcomes. To learn more about the value of preserving your own stem cells for use in future regenerative therapies, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.